|
Volumn 20, Issue 9, 2012, Pages 3119-3127
|
Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
|
Author keywords
Docking; HIV 1; NNRTIs; Reverse transcriptase inhibitors
|
Indexed keywords
2 METHYL 1 (PYRIDIN 4 YLMETHYL) 4 (3,4,5 TRIMETHOXYBENZYLIDENE) 1H IMIDAZOL 5(4H) ONE;
2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 4 (3,4,5 TRIMETHOXYBENZYLIDENE) 1H IMIDAZOL 5(4H) ONE;
4 (2 HYDROXYBENZYLIDENE) 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (2 HYDROXYBENZYLIDENE) 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (2,4 DICHLOROBENZYLIDENE) 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (2,4 DICHLOROBENZYLIDENE) 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (4 CHLOROBENZYLIDENE) 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (4 CHLOROBENZYLIDENE) 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (4 HYDROXY 3 METHOXYBENZYLIDENE) 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (4 METHOXYBENZYLIDENE) 2 METHYL 1 (PYRIDIN 4 YL METHYL) 1H IMIDAZOL 5(4H) ONE;
4 (4 METHOXYBENZYLIDENE) 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (FURAN 2 YLMETHYLENE) 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 (FURAN 2 YLMETHYLENE) 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 [(1H INDOL 3 YL)METHYLENE] 2 METHYL 1 (PYRIDIN 4 YL METHYL) 1H IMIDAZOL 5(4H) ONE;
4 [4 (4 DIMETHYLAMINO)BENZYLIDENE] 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 [4 (DIMETHYLAMINO)BENZYLIDENE] 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 BENZYLIDENE 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 BENZYLIDENE 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 ETHYLIDENE 2 METHYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
4 ETHYLIDENE 2 PHENYL 1 (PYRIDIN 4 YLMETHYL) 1H IMIDAZOL 5(4H) ONE;
CAPRAVIRINE;
DELAVIRDINE;
ETRAVIRINE;
IMIDAZOL 5 ONE;
NEVIRAPINE;
RILPIVIRINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG PROTEIN BINDING;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HYDROPHILICITY;
IC 50;
IN VITRO STUDY;
MOLECULAR DOCKING;
BINDING SITES;
COMPUTER SIMULATION;
HIV REVERSE TRANSCRIPTASE;
HIV-1;
HUMANS;
IMIDAZOLES;
PROTEIN STRUCTURE, TERTIARY;
REVERSE TRANSCRIPTASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 84859914810
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.02.037 Document Type: Article |
Times cited : (24)
|
References (13)
|